The galanin-3 receptor antagonist, SNAP 37889, reduces operant responding for ethanol in alcohol-preferring rats.
OBJECTIVE
The galanin-3 receptor (GALR3) subtype has been identified as having a role in both feeding behaviour and the regulation of emotional states including anxiety. Despite the evidence for an association between galanin and alcohol, the current study is the first to explore the direct role of GALR3 in this context. The present study investigated the potential of the novel selective GALR3 antagonist, SNAP 37889, to reduce anxiety-like behaviour and voluntary ethanol consumption in the iP (alcohol-preferring) rat. This was achieved through a number of behavioural paradigms testing for anxiety, along with the operant self-administration model.


RESULTS
Overall, male iP rats treated with SNAP 37889 at a dose of 30 mg/kg (i.p.) did not show altered locomotor activity or changes in anxiety-like behaviour in the elevated plus maze or light-dark paradigms. Treatment with SNAP 37889 (30 mg/kg, i.p.) reduced operant responding for solutions containing ethanol, sucrose and saccharin. Collectively, results from the current study showed that SNAP 37889 (30 mg/kg, i.p.) is effective in reducing operant responding for ethanol, independent of a sedative effect.


CONCLUSIONS
These findings provide evidence that GALR3 antagonism reduces alcohol consumption and further suggest that GALR3 may be implicated in the rewarding effects of natural and drug reinforcers.
Ash
Belinda L
BL
School of Human Biosciences, La Trobe University, Bundoora, Victoria, Australia.
Zanatta
Shannon D
SD
Williams
Spencer J
SJ
Lawrence
Andrew J
AJ
Djouma
Elvan
E
D000428:Alcohol Drinking / Q000188:drug therapy; D000818:Animals; D001007:Anxiety / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D003216:Conditioning, Operant / Q000187:drug effects; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D051381:Rats; D044093:Receptor, Galanin, Type 3 / Q000037:antagonists & inhibitors*; D012439:Saccharin / Q000008:administration & dosage; D012646:Self Administration; D013395:Sucrose / Q000008:administration & dosage
C510288:1-phenyl-3-((3-(trifluoromethyl)phenyl)imino)-1H-indol-2-one; D007211:Indoles; D044093:Receptor, Galanin, Type 3; D013395:Sucrose; D012439:Saccharin